Prof. Chiun Hsu (Taiwan)
Immuno-oncology for potentially resectable HCC

Dr. Claudia Fulgenzi (Imperial College, London, UK)
Efficacy and safety of frontline systemic therapy

Dr. Andrea Casadei Gardini (Milano, Italy)
What is the place of TKIs in the treatment of HCC

Break

Prof. Andrea Teufel (Heidelberg, Germany)
Radiomics to diagnose and predict response to treatment

Dr. Manon Allaire (Paris, France)
Disparities in access to systemic therapies

Prof. Thomas Berg (Leipzig, Germany)
HCC risk and surveillance

Prof. JF. Dufour (Switzerland)
Closing Remarks